|
Characteristic
|
P value
|
HR
|
95% CI
|
|---|
|
Stage (FIGO)
|
<0.001
| | |
|
III vs. I–II
|
0.181
|
1.95
|
0.74–5.13
|
|
IV vs. I–II
|
<0.001
|
20.60
|
6.11–69.39
|
|
Pre-treatment tumor size (≤4.0 cm vs. >4.0 cm)
|
<0.001
|
0.17
|
0.06–0.4
|
|
Lymph node metastasis (yes vs. no)
|
<0.001
|
0.02
|
<0.01–0.17
|
|
Age (per 1-year increase)
|
0.850
|
1.01
|
0.96–1.05
|
- Patients with unknown lymph node status were excluded from the univariate analysis with the characteristic of lymph node metastasis
-
HR hazard ratio, CI confidence interval, FIGO International Federation of Gynecology and Obstetrics
